Q1 2018

Filed May 21, 2018 · 10-Q · 51 days after period end · 0001654954-18-005720

Q1 2018 · 10-Q

Revenue

$0.00

— vs Q1 2017

Net Income

-$1.07M

N/M vs Q1 2017

EPS Diluted

-$0.24

N/M vs Q1 2017

Gross Profit$0—

Operating Income

Same quarter

Metric	Q1 2018	Q1 2017	Q1 2016	Q1 2015
Revenue	$0.00	$0.00	$0.00	$0.00
Net Income	-$1.07M	-$601.01K	-$234.82K	-$63.81K
EPS Diluted	-$0.24	-$0.02	-$0.54	-$0.13

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Panacea Life Sciences Holdings, Inc. · CIK 1552189 · Engraved from SEC EDGAR